Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes.
#SayHerName: Should Obstetrics and Gynecology Reckon with the Legacy of JM Sims?
The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity.
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer. BMC Cancer. 2022 Apr 23; 22(1):447.
View in:
PubMed
subject areas
Cell Line, Tumor
Cetuximab
Drug Resistance, Neoplasm
ErbB Receptors
Head and Neck Neoplasms
Humans
Neuregulin-1
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
authors with profiles
Ravi Salgia